ÂÜÀòÂÒÂ×

Dan Snyder has a long and varied work experience in the biotechnology and healthcare industries. In 2021, they became the CEO and Founder of The Playbook. In 2022, they took on the role of Head of Commercial Development at iRepertoire, Inc., where they worked on developing the gold standard technologies for immune repertoire sequencing. In 2021, they also became the Head of Commercial at CytoImage, a company developing a blood based single cell multiplex protein imaging platform. In 2019, they joined StoneStable, Inc. as a Board Member. In 2020, they became the Biopharma Business Development Strategy at Freenome and the Head of Commercial Development at Tasso, Inc. From 2006 to 2020, they worked at MolecularMD, where they served as Chief Executive Officer, Chief Operating Officer, and Vice President of Sales and Marketing. From 2003 to 2006, they were the Commercial Lead at Upstate Biotechnology, where they led a highly profitable $6M multiplex immunoassay global reagent business. From 2001 to 2003, they were Vice President of Sales and Marketing at Hemodyne: Virginia Biotechnology Research Park. Lastly, from 1992 to 2001, they were the Founder and Chief Executive Officer of Protein Solutions, a life science research instrumentation company.

Dan Snyder holds a Bachelor of Arts in Economics from the University of Virginia, a Master of Business Administration from the William & Mary Raymond A. Mason School of Business, and a Continuing Education certificate from MIT xPRO in Drug and Medical Device Development: A Strategic Approach, obtained in 2020. Dan also holds three certifications from the Pragmatic Institute obtained in 2021: Focus, Foundations, and PMC Level II.